Adage Capital Partners’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-200,000
| Closed | -$4.31M | – | 926 |
|
|
2024
Q2 | $4.31M | Buy |
200,000
+70,000
| +54% | +$1.51M | 0.01% | 725 |
|
|
2024
Q1 | $3.5M | Sell |
130,000
-10,000
| -7% | -$269K | 0.01% | 732 |
|
|
2023
Q4 | $4.2M | Buy |
+140,000
| New | +$4.2M | 0.01% | 697 |
|
|
2019
Q3 | – | Sell |
-2,157,739
| Closed | -$32.4M | – | 757 |
|
|
2019
Q2 | $32.4M | Sell |
2,157,739
-242,261
| -10% | -$3.63M | 0.08% | 272 |
|
|
2019
Q1 | $42.1M | Buy |
2,400,000
+341,201
| +17% | +$5.98M | 0.11% | 230 |
|
|
2018
Q4 | $30.5M | Buy |
2,058,799
+758,799
| +58% | +$11.2M | 0.08% | 258 |
|
|
2018
Q3 | $32M | Buy |
1,300,000
+100,000
| +8% | +$2.46M | 0.07% | 302 |
|
|
2018
Q2 | $23.6M | Buy |
1,200,000
+200,000
| +20% | +$3.93M | 0.05% | 369 |
|
|
2018
Q1 | $18.8M | Buy |
1,000,000
+500,000
| +100% | +$9.38M | 0.04% | 410 |
|
|
2017
Q4 | $5.22M | Buy |
500,000
+125,000
| +33% | +$1.31M | 0.01% | 621 |
|
|
2017
Q3 | $2.67M | Buy |
375,000
+257,500
| +219% | +$1.83M | 0.01% | 661 |
|
|
2017
Q2 | $893K | Hold |
117,500
| – | – | ﹤0.01% | 684 |
|
|
2017
Q1 | $940K | Hold |
117,500
| – | – | ﹤0.01% | 682 |
|
|
2016
Q4 | $2.87M | Hold |
117,500
| – | – | 0.01% | 639 |
|
|
2016
Q3 | $4.46M | Hold |
117,500
| – | – | 0.01% | 618 |
|
|
2016
Q2 | $3.5M | Buy |
117,500
+48,750
| +71% | +$1.45M | 0.01% | 621 |
|
|
2016
Q1 | $2.04M | Hold |
68,750
| – | – | 0.01% | 645 |
|
|
2015
Q4 | $3.12M | Hold |
68,750
| – | – | 0.01% | 632 |
|
|
2015
Q3 | $2.59M | Buy |
+68,750
| New | +$2.59M | 0.01% | 662 |
|